Quantum Genomics S.A.S.

0D1J - LSE
Save to watchlist

Add to calculator
Overview
Stock analysis
Dividends
Fundamentals
Quantum Genomics S.A.S.
0D1J
-
LSE
Overview
Stock analysis
Dividends
Fundamentals

Stock overview

Save to watchlist
0D1J
Symbol
LSE
Exchange

About stock

Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the treatment of hypertension, as well as in clinical trial for the treatment of heart failure.

It is also developing QGC011 to treat hypertension with combination therapy; and QGC006 and QGC606 drug for the treatment of hypertension and heart failure.

Similar stocks

Report issue